Related Experiment Video
Updated: May 30, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Pre-exposure prophylaxis of HIV
1Department of Skin VD, Government Medical College and SSG Hospital, Vadodara, India.
Pre-exposure prophylaxis (PrEP) offers a new way to prevent HIV using antiretroviral drugs taken before potential exposure. This approach can significantly reduce HIV incidence, especially for women and men who have sex with men.
Area of Science:
- Infectious Diseases
- Public Health
- Pharmacology
Background:
- Pre-exposure prophylaxis (PrEP) involves antiretroviral drugs taken before potential HIV exposure to reduce infection risk.
- Women constitute a significant portion of adult HIV infections, and PrEP offers a female-controlled prevention method.
- Current trials focus on daily oral tenofovir disoproxil fumarate (TDF) alone or with emtricitabine (FTC).
Purpose of the Study:
- To evaluate the efficacy and potential of PrEP as an additional HIV prevention strategy.
- To highlight PrEP's role as a female-controlled method for women unable to negotiate condom use.
- To review ongoing and future trials exploring various PrEP delivery methods.
Main Methods:
- Clinical trials investigating daily oral antiretroviral drugs (TDF, TDF/FTC) for HIV prevention.
- Analysis of data from ongoing studies like the iPrex trial, Bangkok Tenofovir Study, Partners PrEP, FEM-PrEP, and VOICE (MTN-003).
- Exploration of future PrEP strategies including intermittent dosing and alternative delivery routes (vaginal, rectal).
Main Results:
- The iPrex trial demonstrated a 44% reduction in HIV incidence among men who have sex with men (MSM) using daily TDF/FTC.
- Interim guidance from the CDC recommends PrEP for MSM based on trial outcomes.
- Ongoing research continues to assess PrEP's effectiveness across diverse populations and delivery methods.
Conclusions:
- PrEP shows significant potential as an HIV prevention tool, particularly for at-risk populations.
- Effective PrEP implementation requires integration into a comprehensive prevention toolkit, including risk reduction and STI management.
- Addressing concerns such as adherence, acceptability, side effects, and cost is crucial for successful PrEP deployment.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

